AMAbdul Moeed

Abdul Moeed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Abdul Moeed has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Arnim Weber

    Institute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany

    3 shared publications
  • Georg Häcker

    University of Freiburg

    3 shared publications
  • Aladin Haimovici

    Institute of Medical Microbiology and Hygiene, Medical Center, University of Freiburg, Faculty of Medicine, Freiburg, Germany

    2 shared publications
  • Roland Rad

    Institute of Molecular Oncology and Functional Genomics Department of Medicine II and TranslaTUM Cancer Center TUM School of Medicine Technical University of Munich Munich Germany

    2 shared publications
  • Rupert Öllinger

    Institute of Molecular Oncology and Functional Genomics Department of Medicine II and TranslaTUM Cancer Center TUM School of Medicine Technical University of Munich Munich Germany

    2 shared publications
  • Susanne Kirschnek

    Institute of Medical Microbiology and Hygiene Medical Center Faculty of Medicine University of Freiburg Freiburg Germany

    2 shared publications

Latest Publications

  • Open Access

    The second mitochondrial activator of caspases (SMAC) regulates growth, inflammation and mitochondrial integrity in cancer cells

    by Tarek N. Amer, Aladin Haimovici, Susanne Kirschnek, Juliane Vier, Abdul Moeed, Uzochukwu Ukachukwu, Daniela Neugebauer, Philip Neubert, Martin Helmstädter, Severine Kayser, et al.

    SMAC is a mitochondrial intermembrane space protein, which is released during apoptosis and whose known function is antagonism of inhibitor of apoptosis proteins in the cytosol, to facilitate caspase activation. Recent data suggest that SMAC can also be released by sub-lethal signals in the apoptosis pathway, in the absence of cell death. We here explored potential functions of SMAC in non-apoptotic cells. We found that a portion of SMAC is spontaneously released into the cytosol in the absence of apoptosis, regulated by the BCL-2-family proteins BAX and BAK and the fission GTPase DRP1. In cancer cell lines, SMAC was required for the activation of caspases in lethal and non-lethal conditions, while this contribution to caspase-activation was much smaller in non-malignant fibroblast lines. In cells with high levels of cytosolic SMAC, SMAC deficiency reduced in vitro migration, invasion and anchorage-independent growth as well as metastasis in a xenograft model in zebrafish. SMAC-deficient cells further showed a reduced activity in interferon signaling, associated with reduced cytosolic presence of mitochondrial DNA and activation of the stimulator of interferon genes (STING), and SMAC expression levels correlated with interferon-induced genes in cancer data sets. We further found that SMAC can regulate mitochondrial morphology and integrity. Finally, high gene-expression of SMAC was associated with poor prognosis in patients of several cancer types. These results identify SMAC as a regulator of inflammation and growth behavior of cancer cells. They further report a mitochondrial function of SMAC and demonstrate a role of SMAC in human cancer biology across several cancer entities.


  • Open Access

    The caspase-activated DNase promotes cellular senescence

    by Aladin Haimovici, Valentin Rupp, Tarek Amer, Abdul Moeed, Arnim Weber, Georg Häcker

    Cellular senescence is a response to many stressful insults. DNA damage is a consistent feature of senescent cells, but in many cases its source remains unknown. Here, we identify the cellular endonuclease caspase-activated DNase (CAD) as a critical factor in the initiation of senescence. During apoptosis, CAD is activated by caspases and cleaves the genomic DNA of the dying cell. The CAD DNase is also activated by sub-lethal signals in the apoptotic pathway, causing DNA damage in the absence of cell death. We show that sub-lethal signals in the mitochondrial apoptotic pathway induce CAD-dependent senescence. Inducers of cellular senescence, such as oncogenic RAS, type-I interferon, and doxorubicin treatment, also depend on CAD presence for senescence induction. By directly activating CAD experimentally, we demonstrate that its activity is sufficient to induce senescence in human cells. We further investigate the contribution of CAD to senescence in vivo and find substantially reduced signs of senescence in organs of ageing CAD-deficient mice. Our results show that CAD-induced DNA damage in response to various stimuli is an essential contributor to cellular senescence.


  • Open Access

    The Caspase-Activated DNase drives inflammation and contributes to defense against viral infection

    by Abdul Moeed, Nico Thilmany, Frederic Beck, Bhagya K. Puthussery, Noemi Ortmann, Aladin Haimovici, M. Tarek Badr, Elham Bavafaye Haghighi, Melanie Boerries, Rupert Öllinger, et al.

    Mitochondria react to infection with sub-lethal signals in the apoptosis pathway. Mitochondrial signals can be inflammatory but mechanisms are only partially understood. We show that activation of the caspase-activated DNase (CAD) mediates mitochondrial pro-inflammatory functions and substantially contributes to host defense against viral infection. In cells lacking CAD, the pro-inflammatory activity of sub-lethal signals was reduced. Experimental activation of CAD caused transient DNA-damage and a pronounced DNA damage response, involving major kinase signaling pathways, NF-κB and cGAS/STING, driving the production of interferon, cytokines/chemokines and attracting neutrophils. The transcriptional response to CAD-activation was reminiscent of the reaction to microbial infection. CAD-deficient cells had a diminished response to viral infection. Influenza virus infected CAD-deficient mice displayed reduced inflammation in lung tissue, higher viral titers and increased weight loss. Thus, CAD links the mitochondrial apoptosis system and cell death caspases to host defense. CAD-driven DNA damage is a physiological element of the inflammatory response to infection.


  • Open Access

    Efficacy of a Synthetic Antioxidant Treatment in Stabilizing Poultry Byproduct Meal and Subsequent Impact of the Treated Meal on Selected Growth Parameters of Broilers

    by H Ahmad, A Khalique, S Naveed, Mw Zia, Z Rasool, U Zahid, A Moeed

    This study was conducted to investigate the effect of a commercial antioxidant (CAO; Rendox Plus®) treatment in stabilizing the poultry byproduct meal (PBPM) and then the subsequent effect of the treated PBPM on growth of broilers. Five batches A, B, C, D and E of PBPM were treated with CAO at 0, 250, 500, 750 and 1000 mL/ton, respectively and stored for 42 days. Oxidative stability of PBPM was estimated on day 0 and then weekly using Peroxide Value and Thiobarbituric Acid tests. PBPMs treated with 750 &1000 mL/ton presented the least oxidation and were selected to be included in broiler diets. A total of 240 one-day-old non-sexed Hubbard broilers were randomly divided into two flocks of 120 birds each. Each flock was further divided into four groups with three replicates of 10 birds each. The selected PBPMs (D and E) were added at 4%, 5%, 6% and 7% in the starter and grower diets. The experiment lasted for 35 days. The PBPM treated with 1000 mLCAO/ton exhibited the lowest (p<0.05) oxidation level compared to other treated PBPMs. PBPMs with up to 7% CAO inclusion rate did not influence (p>0.05) broiler feed intake, weight gain, feed conversion ratio, final body weight, carcass traits, or mortality rate. It was concluded that CAO was effective in stabilizing PBPM, and up to 7% (70 g/kg) of CAO-treated PBPM can be safely included in broiler diets without any harmful effect on their performance.